Does LENIOLISIB Cause Product dose omission issue? 80 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Product dose omission issue have been filed in association with LENIOLISIB (Joenja). This represents 14.0% of all adverse event reports for LENIOLISIB.
80
Reports of Product dose omission issue with LENIOLISIB
14.0%
of all LENIOLISIB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Product dose omission issue From LENIOLISIB?
Of the 80 reports, 6 (7.5%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENIOLISIB. However, 80 reports have been filed with the FAERS database.
What Other Side Effects Does LENIOLISIB Cause?
Infection (87)
Off label use (51)
Sinusitis (37)
Nasopharyngitis (29)
Headache (28)
Nausea (21)
Alopecia (19)
Fatigue (19)
Pneumonia (19)
Ear infection (18)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which LENIOLISIB Alternatives Have Lower Product dose omission issue Risk?
LENIOLISIB vs LENOGRASTIM
LENIOLISIB vs LENVATINIB
LENIOLISIB vs LEPONEX
LENIOLISIB vs LERCANIDIPINE
LENIOLISIB vs LETAIRIS